Experience and BCC subtypes as determinants of MAL-PDT response: preliminary results of a national Brazilian project
- PMID: 24412582
- DOI: 10.1016/j.pdpdt.2013.11.001
Experience and BCC subtypes as determinants of MAL-PDT response: preliminary results of a national Brazilian project
Abstract
Non-melanoma skin cancer is the most prevalent cancer type in Brazil and worldwide. Photodynamic therapy (PDT) is a noninvasive technique with excellent cosmetic outcome and good curative results, when used for the initial stages of skin cancer. A Brazilian program was established to determine the efficacy of methyl aminolevulinate (MAL)-PDT, using Brazilian device and drug. The equipment is a dual device that combines the photodiagnosis, based on widefield fluorescence, and the treatment at 630nm. A protocol was defined for the treatment of basal cell carcinoma with 20% MAL cream application. The program also involves the training of the medical teams at different Brazilian regions, and with distinct facilities and previous PDT education. In this report we present the partial results of 27 centers with 366 treated BCC lesions in 294 patients. A complete response (CR) was observed in 76.5% (280/366). The better response was observed for superficial BCC, with CR 160 lesions (80.4%), when compared with nodular or pigmented BCC. Experienced centers presented CR of 85.8% and 90.6% for superficial and nodular BCC respectively. A high influence of the previous doctor experience on the CR values was observed, especially due to a better tumor selection.
Keywords: BCC subtypes; Determinants; Doctor experience; National Brazilian project; Non-melanoma skin cancer; Photodynamic therapy.
Copyright © 2013 Elsevier B.V. All rights reserved.
Similar articles
-
Photodynamic therapy with methyl aminolevulinate for primary nodular basal cell carcinoma: results of two randomized studies.Int J Dermatol. 2009 Nov;48(11):1236-45. doi: 10.1111/j.1365-4632.2008.04022.x. Int J Dermatol. 2009. PMID: 20064185 Clinical Trial.
-
Efficacy of photodynamic therapy with methyl aminolevulinate in the treatment of superficial and nodular basal cell carcinoma: an open-label trial.Eur J Dermatol. 2007 Sep-Oct;17(5):412-5. doi: 10.1684/ejd.2007.0239. Epub 2007 Aug 2. Eur J Dermatol. 2007. PMID: 17673385 Clinical Trial.
-
Photodynamic therapy with methyl-5-aminolevulinate for basal cell carcinoma: A systematic review and meta-analysis.Photodiagnosis Photodyn Ther. 2020 Mar;29:101667. doi: 10.1016/j.pdpdt.2020.101667. Epub 2020 Jan 22. Photodiagnosis Photodyn Ther. 2020. PMID: 31978564
-
Methyl aminolevulinate-photodynamic therapy for basal cell carcinoma.Dermatol Clin. 2007 Jan;25(1):89-94. doi: 10.1016/j.det.2006.09.008. Dermatol Clin. 2007. PMID: 17126746 Review.
-
Topical methyl aminolevulinate.Am J Clin Dermatol. 2004;5(2):127-37; discussion 138-40. doi: 10.2165/00128071-200405020-00006. Am J Clin Dermatol. 2004. PMID: 15109276 Review.
Cited by
-
Dual-Agent Photodynamic Therapy with Optical Clearing Eradicates Pigmented Melanoma in Preclinical Tumor Models.Cancers (Basel). 2020 Jul 18;12(7):1956. doi: 10.3390/cancers12071956. Cancers (Basel). 2020. PMID: 32708501 Free PMC article.
-
Topical and intradermal delivery of PpIX precursors for photodynamic therapy with intense pulsed light on porcine skin model.Lasers Med Sci. 2019 Dec;34(9):1781-1790. doi: 10.1007/s10103-019-02771-y. Epub 2019 Mar 22. Lasers Med Sci. 2019. PMID: 30903526
-
Raman Microspectroscopy as a Tool to Elucidate the Efficacy of Topical Formulations Containing Curcumin.Pharmaceuticals (Basel). 2019 Mar 23;12(1):44. doi: 10.3390/ph12010044. Pharmaceuticals (Basel). 2019. PMID: 30909531 Free PMC article.
-
Photodynamic Therapy for Basal Cell Carcinoma: The Clinical Context for Future Research Priorities.Molecules. 2020 Nov 18;25(22):5398. doi: 10.3390/molecules25225398. Molecules. 2020. PMID: 33218174 Free PMC article. Review.
-
Optical clearing agent increases effectiveness of photodynamic therapy in a mouse model of cutaneous melanoma: an analysis by Raman microspectroscopy.Biomed Opt Express. 2020 Oct 19;11(11):6516-6527. doi: 10.1364/BOE.405039. eCollection 2020 Nov 1. Biomed Opt Express. 2020. PMID: 33282505 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials